This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 ETFs You Might Fall for This February
by Sanghamitra Saha
February is not known for good stock returns. A consensus carried out from 1950 to 2021 shows that February ended up offering positive stock returns in 43 years and negative returns in 29 years, per moneychimp.com.
5 ETFs at the Heart of the Commodity Boom
by Sweta Killa
After logging the best year since the financial crisis, commodities continue their hot streak in 2022, with the Bloomberg Commodity Spot Index surging 10.2% so far.
3 Commodity ETFs to Hedge Inflation Risk
by Neena Mishra
We highlight most popular ETFs that provide broad exposure to commodities
Time to Buy Often-Ignored Emerging Market Bond ETFs?
by Sanghamitra Saha
As rising rate worries have crippled the bond market in the United States, investors may bet on the emerging market bond ETFs for better returns and yields.
5 ETF Plays to Make the Most of Red-Hot Inflation
by Sweta Killa
The consumer price index jumped 7% year over year in 2021, the largest 12-month gain since June 1982.
Is Invesco DB US Dollar Index Bullish ETF (UUP) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for UUP
5 ETFs Benefiting From High Inflation
by Sweta Killa
Prices for almost everything, from raw materials to food prices to shipping costs, have surged at the fastest pace in nearly four decades. Investors could make some profits by investing in ETFs benefiting from rising inflation.
4 Agriculture ETF Areas At a One-Year High: Here's Why
by Sanghamitra Saha
Several agricultural commodities specifically surged lately due to weather concerns, rising demand, supply disruptions and a lower greenback.
Is Invesco DB US Dollar Index Bullish ETF (UUP) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for UUP
5 Reasons for the Commodity Boom: ETFs to Play
by Sanghamitra Saha
After a decade of underperformance, commodities are experiencing a huge rally thanks to optimism over global economic growth, reflation trade, widespread vaccination, the chances of approval of more COVID-19 antiviral pills, rising consumer confidence and higher housing price.